- Home
- EP vs ATOS Comparison
EP vs ATOS Comparison
Compare EP & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- ATOS
- Stock Information
- Founded
- EP 1983
- ATOS 2009
- Country
- EP United States
- ATOS United States
- Employees
- EP N/A
- ATOS N/A
- Industry
- EP Oil & Gas Production
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- EP Energy
- ATOS Health Care
- Exchange
- EP Nasdaq
- ATOS Nasdaq
- Market Cap
- EP 169.9M
- ATOS 174.8M
- IPO Year
- EP N/A
- ATOS 2012
- Fundamental
- Price
- EP $5.16
- ATOS $1.45
- Analyst Decision
- EP
- ATOS Strong Buy
- Analyst Count
- EP 0
- ATOS 3
- Target Price
- EP N/A
- ATOS $6.25
- AVG Volume (30 Days)
- EP 36.3K
- ATOS 507.3K
- Earning Date
- EP 11-11-2024
- ATOS 11-12-2024
- Dividend Yield
- EP N/A
- ATOS N/A
- EPS Growth
- EP N/A
- ATOS N/A
- EPS
- EP N/A
- ATOS N/A
- Revenue
- EP $42,871,387.00
- ATOS N/A
- Revenue This Year
- EP N/A
- ATOS N/A
- Revenue Next Year
- EP N/A
- ATOS N/A
- P/E Ratio
- EP N/A
- ATOS N/A
- Revenue Growth
- EP N/A
- ATOS N/A
- 52 Week Low
- EP $4.06
- ATOS $0.62
- 52 Week High
- EP $10.99
- ATOS $2.31
- Technical
- Relative Strength Index (RSI)
- EP 49.16
- ATOS 52.72
- Support Level
- EP $5.07
- ATOS $1.34
- Resistance Level
- EP $5.46
- ATOS $1.48
- Average True Range (ATR)
- EP 0.27
- ATOS 0.06
- MACD
- EP 0.01
- ATOS -0.00
- Stochastic Oscillator
- EP 36.54
- ATOS 45.83
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.